|Day Low/High||10.05 / 10.57|
|52 Wk Low/High||5.27 / 20.47|
Data Presented at 13th Annual ECFS Basic Science Conference on Novel Therapies Targeting Cystic Fibrosis
Company to Hold Investor Conference Call and Webcast to Outline Scientific and Corporate Updates on March 30, 2016
Offering will finance in part acquisition of Patheon Inc. and DPP Pharmaceuticals Business of DSM
Global CDMO company combines DSM Pharmaceutical Products and Patheon
JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be a leading ...